Episode Details
Back to Episodes
AI Risks, Business Automation, Copyright Lawsuits, and Pharma Innovations Transforming Today’s Workforce and Industries
Description
Welcome to the RAIZOR Report for Wednesday January 28th 2026.
This episode covers key AI developments, starting with Dario Amodei warning about AI’s risks, including bioterrorism, economic disruptions, and job displacement, while advocating for stronger regulation. Businesses are adopting advanced AI agents for efficiency, enabling non-technical teams to innovate, while a writer shares how AI transformed his creative workflow. Controversy arises as Snap faces a lawsuit over allegedly misusing creators’ content for AI training, highlighting ethical concerns. Lastly, pharmaceutical giants embrace AI to accelerate clinical trials and cut costs, inspiring smaller healthcare businesses to leverage similar tools for improved operations. Stay informed on AI advancements, opportunities, and challenges.
--Want the links from these podcasts? Subscribe to our newsletter!
ABOUT RAIZOR
Businesses that strategically adopt AI will replace those that don’t. Partnering with RAIZOR gives your business a competitive edge by cutting through inefficient workflows with custom AI-powered solutions.
Let us help you cut costs, boost revenue, and accelerate business growth with AI. Learn more and book an Exploration Call at RAIZOR.